These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38268569)

  • 21. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes.
    Doycheva I; Patel N; Peterson M; Loomba R
    J Diabetes Complications; 2013; 27(3):293-300. PubMed ID: 23312215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
    Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
    Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
    Mattos ÂZ; Debes JD; Vogel A; Arrese M; Revelo X; Pase THS; Manica M; Mattos AA
    World J Gastroenterol; 2022 Jul; 28(28):3595-3607. PubMed ID: 36161041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma.
    Ono M; Fujita K; Kobayashi K; Masaki T
    Hepatol Res; 2023 Jul; 53(7):579-594. PubMed ID: 37154478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
    Makol A; Kanthaje S; Dhiman RK; Kalra N; Chawla YK; Chakraborti A
    Exp Biol Med (Maywood); 2018 Feb; 243(4):323-326. PubMed ID: 29186978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota: A new target for T2DM prevention and treatment.
    Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.
    Chen Y; Wang W; Morgan MP; Robson T; Annett S
    Front Endocrinol (Lausanne); 2023; 14():1148934. PubMed ID: 37361533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
    Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges.
    Ahmad MI; Khan MU; Kodali S; Shetty A; Bell SM; Victor D
    J Hepatocell Carcinoma; 2022; 9():477-496. PubMed ID: 35673598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives.
    Ueno M; Takeda H; Takai A; Seno H
    World J Gastroenterol; 2022 Jul; 28(27):3410-3421. PubMed ID: 36158261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic liver disease in diabetes - From mechanisms to clinical trials.
    Dewidar B; Kahl S; Pafili K; Roden M
    Metabolism; 2020 Oct; 111S():154299. PubMed ID: 32569680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach.
    Grgurevic I; Bozin T; Mikus M; Kukla M; O'Beirne J
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower alpha fetoprotein and higher risk of hepatocellular carcinoma, study from the type 2 diabetes mellitus patients.
    Yang S; Liu L; Luo Y; Chen M; Li N; Xu L; Wang Y; Lin Z; Li H; Qu S
    Diabetes Res Clin Pract; 2018 Sep; 143():239-244. PubMed ID: 30009939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
    Papadakos SP; Ferraro D; Carbone G; Frampton AE; Vennarecci G; Kykalos S; Schizas D; Theocharis S; Machairas N
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.
    Zhang Y; Wang H; Xiao H
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD).
    Zarghamravanbakhsh P; Frenkel M; Poretsky L
    Metabol Open; 2021 Dec; 12():100149. PubMed ID: 34870138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.
    Shin HS; Jun BG; Yi SW
    Clin Mol Hepatol; 2022 Oct; 28(4):773-789. PubMed ID: 35934813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk analysis for hepatocellular carcinoma in patients with chronic hepatitis B-associated cirrhosis complicated by type 2 diabetes mellitus: a 5-year prospective cohort study].
    Tang C; Hu C; Zhou Y; Song Y; Li M; Liao M; Sun J; Zhong C; Zhou L; Lin Z; Zhou Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):313-318. PubMed ID: 33849820
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.